Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
https://www.nature.com/articles/onc2017230.pdf
Reference32 articles.
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
2. El-Serag HB . Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118–1127.
3. Honore B . The rapidly expanding CREC protein family: members, localization, function, and role in disease. Bioessays 2009; 31: 262–277.
4. Ludvigsen M, Jacobsen C, Maunsbach AB, Honore B . Identification and characterization of novel ERC-55 interacting proteins: evidence for the existence of several ERC-55 splicing variants; including the cytosolic ERC-55-C. Proteomics 2009; 9: 5267–5287.
5. Li L, Sun L, Gao F, Jiang J, Yang Y, Li C et al. Stk40 links the pluripotency factor Oct4 to the Erk/MAPK pathway and controls extraembryonic endoderm differentiation. Proc Natl Acad Sci USA 2010; 107: 1402–1407.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Review on EGFR-ERK1/2 signaling cascade: implications on cell proliferation in health and disease;Egyptian Pharmaceutical Journal;2023-10
2. Expression signature and prognostic value of CREC gene family in human colorectal cancer;BMC Cancer;2023-09-18
3. Reticulocalbin 2 promotes the prolifer ation and migration of oral squamous cell carcinoma by regulating the EGFR ERK pathway;Tropical Journal of Pharmaceutical Research;2023-02-02
4. A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma;PeerJ;2023-01-06
5. R eticulocalbin 3 : A Ca 2+ homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance;Cancer Science;2022-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3